ERAS – erasca, inc. (US:NASDAQ)

News

Platform Technologies Drive $211B Surge in Precision Cancer Treatment
Erasca (NASDAQ:ERAS) was given a new $5.00 price target on by analysts at Mizuho.
Analyst Confidence High in Erasca (ERAS) Amid Pipeline Advancement and Earlier Q3 2025 Results [Yahoo! Finance]
Erasca to Present at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
Erasca to Present at the 8th Annual Evercore Healthcare Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com